Acousia Therapeutics
Develops therapy for hearing loss
Acousia Therapeutics has raised €2.5M across 1 funding round from 2 investors, most recently a Early VC round in Dec 2016. Based in Germany; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€2.5M
€2,500,000
Funding rounds
1
Investors
2
distinct backers
Active since
2016-12
latest 2016-12
Funding by year
EUR raised per yearAcousia Therapeutics — funding by year — interactive chart.
Data table
| Acousia Therapeutics — funding by year | |
|---|---|
| 2016 | €2.5M |
Signals
High confidenceRaise-next likelihood8
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-12-01 | Early VC | €2.5M | Boehringer Ingelheim Venture Fund,KfW Bankengruppe | View deal → |
Related news
Similar companies
same sector, similar size- Lophius Biosciences€2.2MGermany · Healthtech
- TNI medical€3.0MGermany · Healthtech
- Bomedus€2.5MGermany · Healthtech
- Machtfit€2.2MGermany · Healthtech
- Medexo GmbH€1.3MGermany · Healthtech
- Dentolo€3.0MGermany · Healthtech
Global coverage: FundingData